Introduction
Autism is a neurodevelopmental disorder affecting speech, behavior, and socialization. It is a lifelong condition with no cure. The mainstay of current treatment for Autism is 1-on-1 behavioral, speech, and occupational therapy. There are no FDA approved drugs to specifically treat Autism, although several drugs are used with limited benefit.
Sirica Therapeutics is developing a digital therapeutic system that integrates virtual reality, video gaming, advanced robotics, and physical exercise in a deeply immersive environment. It is an early-stage startup seeking pre-seed funding.
Autism is the fastest growing developmental disorder, increasing at 8% per year.
Market Opportunity
In the US alone, the lifetime cost of autism over the last 30 years is estimated at $7 trillion and expected to reach $15 trillion over the next decade.
In the US alone, the lifetime cost of autism over the last 30 years is estimated at $7 trillion and expected to reach $15 trillion over the next decade.
Our Solution
Sirica Therapeutics has built a digital therapeutic system that integrates virtual reality, video gaming, advanced robotics, and physical exercise in a deeply immersive environment.
Our Cognitive Sensorimotor Therapy ™ is a scalable, engaging, intelligent, and cost-efficient solution. We have successfully established Safety and Feasibility in our first clinical study involving 9 individuals with Autism. Our next milestone is to conduct a larger Efficacy study.
We are raising a pre-seed round and are inviting the Autism community to participate. We welcome you to join us as we accelerate our journey to bring this solution to the many individuals and families who desperately need it.
Sirica Therapeutics has built a digital therapeutic system that integrates virtual reality, video gaming, advanced robotics, and physical exercise in a deeply immersive environment.
Our Cognitive Sensorimotor Therapy ™ is a scalable, engaging, intelligent, and cost-efficient solution. We have successfully established Safety and Feasibility in our first clinical study involving 9 individuals with Autism. Our next milestone is to conduct a larger Efficacy study.
Our Solution
We are raising a pre-seed round and are inviting the Autism community to participate. We welcome you to join us as we accelerate our journey to bring this solution to the many individuals and families who desperately need it.
We’re offering a future opportunity to invest $250 or more in Sirica Therpautics and make a difference in the lives of people affected by Autism.